Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia × Ribavirin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Hepatocellular 7 Hepatitis C 5 Recurrence 4 Hepatitis C, Chronic 4 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Respiratory Tract Infections 2 Lymphoma, Mantle-Cell 2 Infections 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Wilms Tumor 1 Testicular Neoplasms 1 Teratoma, Testicular 1 Teratoma 1 Seminoma 1 Respiratory Syncytial Virus Infections 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pneumonia 1 Neuroblastoma 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Malignant Solid Tumor 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Cyclophosphamide 318 Cytarabine 259 fludarabine phosphate 178 Methotrexate 163 Filgrastim 143 Etoposide 128 Busulfan 128 fludarabine 114 Rituximab 114 Peripheral Blood Stem Cell Transplantation 112 Radiotherapy 101 Vincristine 93 Cyclosporine 87 Daunorubicin 84 Dexamethasone 83 Antilymphocyte Serum 83 Mycophenolic Acid 75 Melphalan 75 Whole-Body Irradiation 74 Tacrolimus 71 Imatinib Mesylate 64 Idarubicin 64 Azacitidine 60 Mercaptopurine 58 Granulocyte Colony-Stimulating Factor 55 Doxorubicin 54 Methylprednisolone 53 Prednisone 51 Mitoxantrone 48 Clofarabine 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00559091 2022-12-22

Borden-001

Jewish General Hospital

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡